汇添富国证港股通创新药ETF(159570)资产负债表
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 资产 |
| 银行存款 |
- |
- |
- |
| 结算备付金 |
199,640,828.70 |
4,098.16 |
2,710.27 |
| 存出保证金 |
79,914,355.02 |
14.76 |
18.75 |
| 交易性金融资产 |
7,648,012,961.26 |
640,485,268.41 |
233,987,895.06 |
| 其中：股票投资 |
7,648,012,961.26 |
640,485,268.41 |
233,987,895.06 |
| 债券投资 |
- |
- |
- |
| 资产支持证券投资 |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
| 应收证券清算款 |
- |
2,600,370.76 |
- |
| 应收利息 |
- |
- |
- |
| 应收股利 |
8,124,234.43 |
- |
683,124.90 |
| 应收申购款 |
- |
- |
- |
| 其他资产 |
- |
- |
- |
| 资产总计 |
8,122,897,789.84 |
656,523,342.78 |
240,898,973.74 |
| 负 债 |
| 短期借款 |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
| 应付证券清算款 |
316,741,898.16 |
2,902,511.52 |
53.17 |
| 应付赎回款 |
- |
- |
- |
| 应付管理人报酬 |
2,362,655.12 |
269,430.75 |
95,328.46 |
| 应付托管费 |
472,531.01 |
53,886.15 |
19,065.70 |
| 应付销售服务费 |
- |
- |
- |
| 应付交易费用 |
- |
- |
- |
| 应交税费 |
- |
- |
- |
| 应付利息 |
- |
- |
- |
| 应付利润 |
- |
- |
- |
| 其他负债 |
1,405,775.46 |
216,804.89 |
152,313.10 |
| 负债合计 |
320,982,859.75 |
3,442,633.31 |
266,760.43 |
| 所有者权益 |
| 实收基金 |
5,128,597,142.00 |
681,597,142.00 |
308,597,142.00 |
| 未分配利润 |
2,673,317,788.09 |
-28,516,432.53 |
-67,964,928.69 |
| 所有者权益合计 |
7,801,914,930.09 |
653,080,709.47 |
240,632,213.31 |
| 负债及所有者权益总计 |
8,122,897,789.84 |
656,523,342.78 |
240,898,973.74 |
微信公众号
证券之星APP
基本资料
